Suppr超能文献

成功电复律后正常窦性心律长期维持的预测因素。

Predictors of long-term maintenance of normal sinus rhythm after successful electrical cardioversion.

作者信息

Abu-El-Haija Basil, Giudici Michael C

机构信息

Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

出版信息

Clin Cardiol. 2014 Jun;37(6):381-5. doi: 10.1002/clc.22276. Epub 2014 Apr 3.

Abstract

Electrical cardioversion (EC) for atrial fibrillation (AF) is a common procedure performed in an attempt to restore normal sinus rhythm (NSR). Many factors predict long-term maintenance of NSR and the risk of AF recurrence. The duration of AF, cardiac size and function, rheumatic heart disease, significant mitral valve disease, left atrial enlargement, and older age are among the most common recognized factors. A number of interventions can potentially decrease the AF recurrence rate. Identifying and treating reversible causes and the use of antiarrhythmic medications in certain situations can help decrease the risk of AF recurrence. The role of the newer anticoagulants is expanding, and wider application is expected in the near future. We hope that this summary will serve as a guide to physicians and healthcare providers to address the question of who should undergo cardioversion, as there are patients who are most likely to benefit from this procedure and others that will revert back into AF within a short period. To identify who would benefit most from EC and have a reasonable chance of long-term maintenance of NSR, a thorough evaluation of each individual patient should be performed to tailor the best therapy to each individual.

摘要

心房颤动(AF)的电复律(EC)是一种常见的操作,旨在恢复正常窦性心律(NSR)。许多因素可预测NSR的长期维持及AF复发风险。AF持续时间、心脏大小和功能、风湿性心脏病、显著二尖瓣疾病、左心房扩大及高龄是最常见的公认因素。一些干预措施可能降低AF复发率。识别和治疗可逆病因以及在某些情况下使用抗心律失常药物有助于降低AF复发风险。新型抗凝药物的作用正在扩大,预计在不久的将来会得到更广泛应用。我们希望本综述能为医生和医疗服务提供者提供指导,以解决谁应接受复律这一问题,因为有些患者最可能从该操作中获益,而其他患者则会在短期内复发为AF。为了确定谁能从EC中获益最大并有合理机会长期维持NSR,应对每位患者进行全面评估,以便为其量身定制最佳治疗方案。

相似文献

1
Predictors of long-term maintenance of normal sinus rhythm after successful electrical cardioversion.
Clin Cardiol. 2014 Jun;37(6):381-5. doi: 10.1002/clc.22276. Epub 2014 Apr 3.
2
Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
Postgrad Med. 2012 Nov;124(6):26-35. doi: 10.3810/pgm.2012.11.2610.
8
[Atrial fibrillation: always cardioversion? No].
Ital Heart J Suppl. 2002 Jan;3(1):81-90.
9
Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
Heart. 2010 Mar;96(5):333-8. doi: 10.1136/hrt.2008.155812. Epub 2009 Nov 11.

本文引用的文献

2
Atrial fibrillation in obstructive sleep apnea.
World J Cardiol. 2013 Jun 26;5(6):157-63. doi: 10.4330/wjc.v5.i6.157.
3
Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.
Int J Clin Pract. 2013 Jun;67(6):536-43. doi: 10.1111/ijcp.12063. Epub 2013 Apr 5.
9
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
10
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验